Azanta is an international market leader within certain niche-specialty pharma product categories, employing innovative repositioning and drug formulation strategies, offering patients the best treatment alternatives. We are a specialty biopharmaceutical company developing treatments for orphan oncology, women's health indications and addiction medicine. Our lead product candidates are Nimoral and Angusta®. To support our operations and to subsidize our development of Nimoral and Angusta® and other orphan oncology and women's health care product candidates, we currently market and distribute a portfolio of specialty pharmaceuticals products pursuant to third party distribution agreements. Constantly, Azanta looks for new licensing opportunities and partners with products to supplement and broaden our existing portfolio whilst at the same time addressing unmet treatment needs.
View Top Employees from Azanta A/SWebsite | https://www.azanta.com |
Revenue | $7 million |
Employees | 9 (3 on RocketReach) |
Founded | 2007 |
Address | Gearhalsvej 1, Valby, Capital Region 2500, DK |
Phone | (457) 025-9545 |
Technologies | |
Industry | Pharmaceuticals, Manufacturing General, Medical Device, Oncology, Manufacturing, Health Care, Women & Men Healthcare, Pharmaceutical, Addiction Medicine, Wholesale, Commerce and Shopping |
Web Rank | 4 Million |
Keywords | Azanta Danmark A/S, Copenhagen Biotech Companies, Pharma Companies In Denmark |
Competitors | Archimedes Pharma, Embera NeuroTherapeutics, HLL LIFECARE LIMITED, QOL Medical LLC, Sinclair Pharma Spain |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Azanta A/S employee's phone or email?
The Azanta A/S annual revenue was $7 million in 2024.
3 people are employed at Azanta A/S.
Azanta A/S is based in Valby, Capital Region.
The NAICS codes for Azanta A/S are [32541, 32, 325, 3254].
The SIC codes for Azanta A/S are [28, 283].